Edith A. Nutescu - Concepedia

Author

Edith A. Nutescu

Also Known As

Duarte, Julio D., E A Nutescu, E NUTESCU, E Nutescu, E. A Nutescu, E. A. Nutescu, E. Nutescu, E.A. Nutescu, EA Nutescu, Edith A Nutescu

287

Publications

7.4K

Citations

H-Index

Concepts

All Affiliations

University of Illinois Chicago Janssen Scientific Affairs (United States)University of Florida Janssen (United States)University of Washington

About

Edith A. Nutescu is an author at University of Illinois Chicago specializing in medicine, thrombosis, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	24	1.3K
2	Public Health	13	16	771
3	Emergency Medicine	6	6	105
4	Nursing	1	1	11
5	Blood Transplantation	1	1	12

Edith A. Nutescu

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans Harumi Takahashi, G. Wilkinson, Edith A. Nutescu, Pharmacogenetics and Genomics	2006	374
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention Larisa H. Cavallari, Craig R. Lee, Amber L. Beitelshees, JACC: Cardiovascular Interventions Percutaneous Coronary InterventionThrombosisMultisite InvestigationCardiovascular DiseaseBlood Platelet	2017	303
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study Minoli A. Perera, Larisa H. Cavallari, Nita A. Limdi, The Lancet Genome-wide Association StudyThrombosisGenetic VariantsEpidemiologyAllelic Variant	2013	272
Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans Larisa H. Cavallari, Taimour Langaee, Kathryn M. Momary, Clinical Pharmacology & Therapeutics	2010	199
Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes Adam J. Duhl, Michael J. Paidas, Serdar Ural, American Journal of Obstetrics and Gynecology ThrombosisVenous ThrombosisAbortionAntithrombotic TherapyMaternal Cardiovascular Outcome	2007	182
Factors that Influence Prescribing Decisions Glen T. Schumock, Surrey M. Walton, Hayley Y. Park, Annals of Pharmacotherapy	2004	124
Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum David García, Daniel M. Witt, Elaine M. Hylek, Annals of Pharmacotherapy	2008	104
Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans Katarzyna Drozda, Shan S. Wong, Shitalben Patel, Pharmacogenetics and Genomics	2014	98
Real‐World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation Beenish S. Manzoor, Todd A. Lee, Lisa K. Sharp, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2017	89
Decreased Warfarin Clearance Associated With the CYP2C9 R150H (*8) Polymorphism Yong Liu, Ho Jung Jeong, Harumi Takahashi, Clinical Pharmacology & Therapeutics Human PolymorphismImmunologyPathologyGenetic EpidemiologyPharmacotherapy	2012	86

Page 1